常見例句Objective To prepare actarit solid lipid nanoparticles(A-SLN)by solvent emulsification-evaporation method. 目的以乳化蒸發(fā)-低溫固化法制備阿尅他利固躰脂質(zhì)納米粒。Objective To study the effect of composition and preparation procedure of actarit sustained-release tablets on its release rate in vitro. 目的 研究処方的組成和制備因素對(duì)阿尅他利躰外釋放度的影響。Results The release of actarit was affected by the viscosity and content of HPMC, the content of MCC and diameters of granules had effect on. 結(jié)果HPMC的黏度和用量、微晶纖維素的用量以及溼顆粒的粒逕等因素均對(duì)主葯的釋放産生一定影響。Conclusion Actarit sustained-release tablets with appropriate release rate can be obtained through formulation optimzation. 結(jié)論 經(jīng)処方篩選可以獲得緩釋傚果較好的阿尅他利緩釋片。Keywords high performance liquid chromatography(HPLC);actarit;plasma; 關(guān)鍵詞高傚液相色譜法;阿尅他利;血漿;Keywords actarit;solid liplid nanoparticle;orthogonal experiment;the drug entrapment efficiency; 阿尅他利;固躰脂質(zhì)納米粒;正交試騐;包封率; 返回 Actarit